Cornelia Ursula Kunz

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Finite Element Analysis

Top Venues

Statistics in medicine

Pharmaceutical statistics

Statistics in biopharmaceutical research

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen Schüürhuis, Frank Konietschke, Cornelia Ursula Kunz
A two-stage group-sequential design for delayed treatment responses with the possibility of trial restart. Statistics in medicine 43 (12) (2024)
Stephen Schüürhuis, Frank Konietschke, Cornelia Ursula Kunz
A two-stage group-sequential design for delayed treatment responses with the possibility of trial restart. Statistics in medicine (2024)
Stella Jinran Zhan, Cornelia Ursula Kunz, Nigel Stallard
Should the two-trial paradigm still be the gold standard in drug assessment? Pharmaceutical statistics (2022)
Cornelia Ursula Kunz, Silke Jörgens, Frank Bretz, Nigel Stallard, Kelly Van Lancker, Dong Xi, Sarah Zohar, Christoph Gerlinger, Tim Friede
Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue? Statistics in biopharmaceutical research 12 (4) (2020)
Cornelia Ursula Kunz, Thomas Jaki, Nigel Stallard
An alternative method to analyse the biomarker-strategy design. Statistics in medicine 37 (30) (2018)